This can be considered as an exciting development in the field of biotechnology. We all know that Alzheimer is a disease for which there is still not a permanent cure but Enkam Pharmaceuticals which is a small Danish firm with a workforce of just fourteen people has come out with a drug called FGL which has been found out to be effective in the treatment of Alzheimer patients. This drug has been found out to be effective in improving memory and re-establishing spoilt nerve cells. It is different from other drugs available in the market as these are concerned with removing the protein which is thought to cause Alzheimer. It is being contemplated whether this drug would be able to enter the markets as figures tell that there is just a five to ten percent chance that a new drug is able to make it to the shelves. The major factor which comes against it is the return factor and due to this at times effective drugs fails to reach to the people.
Tag Archives: bioAlzheimer’s
This new chemical compound could result in the development of a drug treatment for Alzheimer’s disease. All thanks to the scientists at University of Liverpool who created this new chemical compound. For this purpose long chain sugars called Heparan Sulphates was used for producing a new compound which could prevent the formation of clumps of small proteins that formed in the brain. These clumps have been found out to interfere with the normal functioning of the cells which leads to progressive memory loss associated with Alzheimer’s disease. As Per Professor Jerry Turnbull: We have developed a new class of compounds called ‘engineered heparins’ that could possibly be developed into drugs to stop A-beta peptides in the brain from forming and for the first time treat the underlying cause of Alzheimer’s. It is expected that the discovery of HS sugars might play a pivotal role in limiting the development of Alzheimer’s disease.